We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IBTH:NASDAQiShares iBonds Dec 2027 Term Treasury ETF analysis

Data as of Sep 14, 2026 - not real-time

Latest price
$22.31
Risk: low
2/10Low risk

Summary

iShares iBonds Dec 2027 Term Treasury ETF trades at $22.31, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Relative strength is 39.2 — approaching oversold — and the MACD signal is bearish. The recent range runs from support at $22.29 up to resistance at $22.39.
The 0.07% expense ratio is very low for its category, and the fund manages $2.38B in assets.
Risk scores 2 out of 10, which is low for this asset class. With 30-day volatility of 1.4% and a beta of 0.00, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 89 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.

Market outlook

Short term

< 1 year

Neutral

Model confidence3/103 out of 10

Key factors

  • Trading below the 200-day average of 22.41
  • MACD momentum is negative
  • RSI at 39.2 is in neutral territory

Medium term

1–3 years

Neutral

Model confidence3/103 out of 10

Key factors

  • Trading below the 200-day average of 22.41
  • MACD momentum is negative
  • Low expense ratio of 0.07%

Long term

> 3 years

Neutral

Model confidence2/102 out of 10

Key factors

  • Low expense ratio of 0.07%
  • 30-day volatility of 1.4%
  • Beta of 0.00 versus the benchmark

Key metrics

Fund metrics

Expense Ratio0.07%
AUM$2.4B
Inception Date2020-02-25
Avg Daily Volume579,590
Premium/Discount0.00%
Tracking Error0.00%
Dividend Yield3.78%

Technical analysis

TrendNeutral
RSI39.2
Support$22.29
Resistance$22.39
MA 20$22.35
MA 50$22.34
MA 200$22.41
MACDBearish
VolumeStable
Fear & Greed Index89.3

Risk assessment

Beta0.00
Volatility1.40%
Sector RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.